| Name | Title | Contact Details |
|---|---|---|
Andrew Cronauer |
Associate General Counsel | Profile |
Shannon Moesaa |
Associate General Counsel | Profile |
Mark Longer |
Vice President, Regulatory Affairs and Quality | Profile |
Lorus Therapeutics Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.
Ocularis Pharma, Inc. is a Riverside, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Valensa International is a Eustis, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharmagenesis Inc is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.